Literature DB >> 3202372

High levels of transforming growth factor-beta are present in the epithelial lining fluid of the normal human lower respiratory tract.

K Yamauchi1, Y Martinet, P Basset, G A Fells, R G Crystal.   

Abstract

Transforming growth factor-beta (TGF-beta), a mediator capable of modulating a broad range of effects on the behavior of many normal cells, was found in high concentrations in the epithelial lining fluid (ELF) of the normal human lower respiratory tract. Although plasma contained small amounts of TGF-beta, the concentrations of TGF-beta in normal ELF were in the 200 to 300 pM range, more than 15-fold higher. This ELF TGF-beta had similar physical characteristics to purified human platelet TGF-beta, competed with platelet TGF-beta for its receptor on A549 carcinoma cells, and stimulated the anchorage-independent growth of NRK cells in soft agar in the presence of epidermal growth factor. Furthermore, ELF TGF-beta suppressed diploid lung fibroblast proliferation in a dose-dependent fashion similar to platelet TGF-beta. In the context of these observations and with the known biologic properties of this molecule, TGF-beta in ELF has the potential to play a role in a variety of cellular processes in the lower respiratory tract.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3202372     DOI: 10.1164/ajrccm/137.6.1360

Source DB:  PubMed          Journal:  Am Rev Respir Dis        ISSN: 0003-0805


  19 in total

Review 1.  Cytokines in asthma.

Authors:  K F Chung; P J Barnes
Journal:  Thorax       Date:  1999-09       Impact factor: 9.139

2.  Striking the right balance; the role of cytokines in mycobacterial disease.

Authors:  C Moreno; A J Rees
Journal:  Clin Exp Immunol       Date:  1993-10       Impact factor: 4.330

3.  TGF-beta antibodies: a novel treatment for pulmonary fibrosis?

Authors:  G J Laurent; R K Coker; R J McAnulty
Journal:  Thorax       Date:  1993-10       Impact factor: 9.139

4.  Transforming growth factor-beta activity in sheep lung lymph during the development of pulmonary hypertension.

Authors:  E A Perkett; R M Lyons; H L Moses; K L Brigham; B Meyrick
Journal:  J Clin Invest       Date:  1990-11       Impact factor: 14.808

5.  Expression of mucosa-related integrin alphaEbeta7 on alveolar T cells in interstitial lung diseases.

Authors:  J Lohmeyer; J Friedrich; F Grimminger; U Maus; R Tenter; H Morr; H G Velcovsky; W Seeger; S Rosseau
Journal:  Clin Exp Immunol       Date:  1999-05       Impact factor: 4.330

6.  Measurements of hormonal peptides in the bronchoalveolar fluid as tumor markers of lung cancer.

Authors:  A E Calogero; R Polosa; E Neville; R D'Agata
Journal:  J Endocrinol Invest       Date:  1995-05       Impact factor: 4.256

7.  Transforming growth factor beta 1 gene expression in human airways.

Authors:  J D Aubert; B I Dalal; T R Bai; C R Roberts; S Hayashi; J C Hogg
Journal:  Thorax       Date:  1994-03       Impact factor: 9.139

8.  Transforming growth factor beta in normal human lung: preferential location in bronchial epithelial cells.

Authors:  A Magnan; I Frachon; B Rain; M Peuchmaur; G Monti; B Lenot; M Fattal; G Simonneau; P Galanaud; D Emilie
Journal:  Thorax       Date:  1994-08       Impact factor: 9.139

9.  Epidermal growth factor-like molecular species in normal bronchoalveolar lavage fluid.

Authors:  R K Kumar; R O'Grady; N Di Girolamo
Journal:  Lung       Date:  1996       Impact factor: 2.584

10.  Spontaneous production of transforming growth factor-beta 2 by primary cultures of bronchial epithelial cells. Effects on cell behavior in vitro.

Authors:  O Sacco; D Romberger; A Rizzino; J D Beckmann; S I Rennard; J R Spurzem
Journal:  J Clin Invest       Date:  1992-10       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.